Volume 11, Number 1—January 2005
Research
Anti–SARS-CoV Immunoglobulin G in Healthcare Workers, Guangzhou, China
Table 2
SARS-related information | First Affiliated Hospital | Second Affiliated Hospital | Third Affiliated Hospital | Affiliated Cancer Hospital | Fifth Affiliated Hospital |
---|---|---|---|---|---|
In SARS-epidemic area? | Yes | Yes | Yes | Yes | No |
No. healthcare workers exposed to SARS* | 548 | 421 | 425 | 0 | 0 |
No. healthcare workers surveyed | 389 | 361 | 397 | 371 | 338 |
No. days when SARS patients were in the hospital | 120 | 110 | 102 | 0 | 0 |
No. probable SARS patients cared for | 122 | 150 | 31 | 0 | 0 |
No. suspected SARS patients cared for | 102 | 50 | 30 | 3 | 0 |
No. SARS patients who required tracheal intubation | 10 | 0 | 1 | 0 | 0 |
No. SARS patients who required tracheotomy | 0 | 1 | 2 | 0 | 0 |
Cared for the index patient?† | No | Yes | Yes | 0 | 0 |
No. healthcare workers who had SARS‡ in SARS wards | 0 | 80 | 20 | 0 | 0 |
No. healthcare workers who had from SARS in non-SARS wards | 3 | 10 | 2 | 0 | 0 |
*This refers to healthcare workers caring for SARS patients and laboratory personnel handling specimens from SARS patients.
†The index patient was identified as a superspreader who subsequently infected >100 persons (both healthcare workers and other patients and family members in the Second Hospital and Third Hospital).
‡According to the clinical and epidemiologic case definition.
Page created: April 14, 2011
Page updated: April 14, 2011
Page reviewed: April 14, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.